ILLUMINA VENTURES

Portfolio Company Spotlight

Pioneering a new approach to digital PCR

November 2019 - Fascinating life science innovations are emerging from young, entrepreneurial teams of scientists in Europe today, including in and around Paris. Illumina Ventures has recently invested in Paris-based, Stilla Technologies, a company pioneering a new approach to digital PCR.

Imagine How Genomics Will Transform Our Future.

WATCH THE VIDEO